Former Zynex Chairman Indicted for Fraud, Removed from Board Amid Bankruptcy

summarizeSummary

Zynex announced the immediate removal of former Chairman Thomas Sandgaard following his federal indictment for health care and securities fraud, further complicating the company's ongoing Chapter 11 reorganization.

check_boxKey Events

• Former Chairman Removed Due to Fraud Indictment

  Thomas Sandgaard was immediately removed from all positions, including Chair and member of the Board, following his federal indictment on January 21, 2026, for alleged health care and securities fraud offenses.

• Equity Awards and Compensation Terminated

  All unvested equity awards and existing cash compensation arrangements previously granted to Mr. Sandgaard were terminated and canceled.

• New Board Chair Appointed

  Steven Dyson, the Company's Chief Executive Officer and current Board member, was appointed to serve as Chair of the Board, effective immediately.

• Board Size Reduced

  The Board approved a decrease in the number of directors from seven to six, effective immediately.

auto_awesomeAnalysis

This filing reveals a critical legal and governance crisis for Zynex, coming shortly after its Chapter 11 bankruptcy filing. The federal indictment of its former Chairman for fraud charges is a severe blow to the company's reputation and highlights potential underlying issues that contributed to its financial distress. While the company has appointed a new Chair and emphasized an overhaul of its leadership and compliance, the indictment adds another layer of uncertainty and negative sentiment. Investors should be aware that this development further complicates the already high-risk situation for equity holders, who have already been warned of significant losses in the ongoing bankruptcy proceedings.